| 摘要 |
The present invention relates to the use of a compound of general Formula (1), for the treatment of diseases characterized by abnormal cell proliferation in a human or non-human mammalian body by inhibition of polo like kinases as mitotic regulators like cancer selected from the group consisting of carcinomas, sarcomas, melanomas, myeloma, hematologic neoplasias, lymphomas, childhood cancers and leukemia, autoimmune disorders selected from the group consisting of amyloidosis, systemic lupus erythematosus, rheumatoid arthritis, Crohn~s disease, multiphe sclerosis, systemic sclerosis (scleroderma), mixed connective tissue disease, Sjögren~s syndrome, ankylosing spondylitis, autoimmune vasculitis, Behcet~s syndrome, psoriasis, autoimmune arthritis, sarcoidosis, diabetes mellitus and fungous diseases. |
